首页> 外国专利> SMART POLYMERIC NANOPARTICLES WHICH OVERCOME MULTIDRUG RESISTANCE TO CANCER CHEMOTHERAPEUTICS AND TREATMENT-RELATED SYSTEMIC TOXICITY

SMART POLYMERIC NANOPARTICLES WHICH OVERCOME MULTIDRUG RESISTANCE TO CANCER CHEMOTHERAPEUTICS AND TREATMENT-RELATED SYSTEMIC TOXICITY

机译:克服了对药物化疗和治疗相关的全身毒性的多药耐药性的智能聚合物纳米颗粒

摘要

Polymeric nanoparticles with a hydrophobic core that encapsulates curcumin and a hydrophilic shell with one or more chemotherapeutic agents (e.g., doxorubicin) associated with the shell surface are formed from N-isopropylacryl amide (NEPAAM), acrylic acid (AA), and at least one vinyl monomer selected from the group consisting of vinyl acetate, 4-vinyl benzoic acid, methylmethacrylate, vinylmethacrylate, N-vinylpyrrolidone, N-vinyl piperidone, N-vinyl caprolacum, N-vinyl carbazole, and styrene, where the NIPAAM, the AA, and the vinyl monomer are present at molar ratios of 50-70:10-30:10-30 for NIPAAM:AA:vinyl monomer. These nanoparticles effectively overcome multidrug resistance and ameliorate cardiomyopathy in vivo.
机译:具有疏水性核的聚合物纳米颗粒由N-异丙基丙烯酰胺(NEPAAM),丙烯酸(AA)和至少一种形成,该纳米颗粒具有包裹姜黄素的亲水性纳米颗粒和具有与壳表面缔合的一种或多种化学治疗剂(例如,阿霉素)的亲水壳。选自乙酸乙烯酯,4-乙烯基苯甲酸,甲基丙烯酸甲酯,甲基丙烯酸甲酯,N-乙烯基吡咯烷酮,N-乙烯基哌啶酮,N-乙烯基己内酰胺,N-乙烯基咔唑和苯乙烯的乙烯基单体,其中NIPAAM,AA,对于NIPAAM:AA:乙烯基单体,乙烯基单体的摩尔比为50-70:10-30:10-30。这些纳米颗粒可有效克服多药耐药性并改善体内心肌病。

著录项

  • 公开/公告号EP2648760A4

    专利类型

  • 公开/公告日2015-09-16

    原文格式PDF

  • 申请/专利权人 THE JOHNS HOPKINS UNIVERSITY;

    申请/专利号EP20110847391

  • 发明设计人 MAITRA ANIRBAN;PRAMANIK DIPANKAR;

    申请日2011-12-08

  • 分类号A61K47/48;A61K9;A61K9/127;A61K9/51;A61K31/12;A61K31/704;A61K31/7042;A61K45/06;A61P35;C08F20/06;C08F20/56;C08F220/06;C08F220/56;C08F226/10;

  • 国家 EP

  • 入库时间 2022-08-21 15:06:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号